Stock Track | Zylox-Tonbridge Medical Soars 5.27% Intraday on Strong 2025 Earnings and Acquisition News

Stock Track
Mar 18

Shares of Zylox-Tonbridge Medical Technology (ZYLOXTB) soared 5.27% during intraday trading on Wednesday.

The significant price movement follows the company's release of its 2025 financial results, which showed profit attributable to equity holders more than doubled to 244.4 million yuan from 100.3 million yuan a year earlier. Revenue also saw strong growth, increasing by 35% to 1.06 billion yuan.

Investor sentiment was further buoyed by a separate announcement that the company exercised an option to acquire an additional 11% stake in German medical technology firm Optimed Holding, a strategic move to expand its business portfolio. The board has also proposed a final dividend, pending shareholder approval.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10